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Mechanisms of Chloroform and Carbon
Tetrachioride Toxicity in Primary Cultured
Mouse Hepatocytes
by Randall J. Ruch,* James E. Klaunig,*t Norman E.
Schultz,* Augusta B. Askari,* David A. Lacher,* Michael A.
Pereira,§ and Peter J. Goldblatt*
Mechanisms of chloroform (CHCI3) and carbon tetrachloride (CCI4) toxicity to primary cultured male
B6C3F1 mouse hepatocytes were investigated. The cytotoxicity of both CHCI3 and CC14 was dose- and
duration-dependent. Maximal hepatocyte toxicity, as determined by lactate dehydrogenase leakage into
the culture medium, occurred with the highest concentrations of CHC13 (5 mM) and CC14 (2.5 mM) used
and with the longest duration of treatment (20 hr). CC14 was approximately 16 times more toxic than
CHCI3 to the hepatocytes. The toxicity of these compounds was decreased by adding the mixed function
oxidase system (MFOS) inhibitor, SKF-525A (25,uM) to the cultures. The addition ofdiethyl maleate (0.25
mM), which depletes intracellular glutathione (GSH)-potentiated CHCl3 and CC14 toxicity. The toxicity
ofCHCl3 and CC14 could also be decreased by adding the antioxidants N,N'-diphenyl-p-phenylenediamine
(DPPD) (25 R,M), a-tocopherol acetate (Vitamin E) (0.1 mM), or superoxide dismutase (SOD) (100 U/mL)
to the cultures. These results suggest that: in mouse hepatocytes, both CHC13 and CC14 are metabolized
to toxic components by the MFOS; GSH plays a role in detoxifying those metabolites; free radicals are
produced during the metabolism ofCHC13 and CC14; and free radicals may be important mediators ofthe
toxicity of these two halomethanes.
Introduction
Chloroform (CHC13) and carbon tetrachloride (CC14)
are formed asby-products ofsewage and drinkingwater
chlorination and have been identified in public drinking
water (1). Both compounds are toxic tomammalian liver
in vivo and to isolated liver cells, with CC14 being more
toxic than CHC13 (2). CC14 is hepatocarcinogenic in both
rats and mice (3), whereas CHC13 has been shown to be
hepatocarcinogenic only in the B6C3F1 strain of mouse
when administered by corn oil gavage (4). Both com-
pounds may be functioning as liver tumor promoters
(5).
The metabolism ofCC14 and CHC13 mayprovide clues
to their relative cytotoxic potency and their capability
as tumor promoters. It is becoming evident that free
radicals generated during xenobiotic metabolism play a
role in cellular toxicity (6), abnormal growth control (7),
and tumor promotion (8). The metabolism of CC14 and
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CHC13 has been extensively studied in both rats and
mice. The first stepin CC14metabolismis aone-electron
reduction and homolytic cleavage catalyzed by cyto-
chrome P450 of the mixed function oxidase system
(MFOS) toyield thetrichloromethylradical(9) [Eq.(1)].
CCl4 + e& -+ CC13 + Cl- (1)
P450 is maintained in the reduced form by reduced nic-
otinamide adenine dinucleotide (NADPH). The 'CC13
radical rapidly reacts with molecular oxygen to form
the trichloromethylperoxyl radical (10) [Eq. (2)].
*CC13 + 027+OOCCl3 (2)
The 'OOCC13radicalismoreelectrophilic thanthe 'CC13
radical and may be more responsible for attacks on un-
saturated fatty acids, leading to lipid peroxidation (10).
'CC13 may be more involved in covalent binding reac-
tions of CC14 (10).
CHC13 is first metabolized by a cytochrome P450-cat-
alyzed hydroxylation to trichloromethanol (CC130H),
which spontaneously dehydrochlorinates to the toxic
component, phosgene (COC12) (11) [Eq. (3)].
CHCL3-[CCl3O0H]---COCl2 +HCl (3)
Phosgene can covalently bind to macromolecules if not
detoxified by conjugation with glutathione (GSH), orRUCH ET AL.
can be further metabolized to carbon dioxide (CO2) by
reaction with water (11). It has also been suggested
that free radicals are generated during CHC13 metab-
olism and that they play a role in CHC13 toxicity (12,
13). Most studies, however, have failed to detect en-
hanced levels of free radicals or of lipid peroxidation,
although nostudyhas usedthe B6C3F1 strain ofmouse.
To provide evidence that the hepatotoxicity ofCHC13
and CC14 in B6C3F1 mice might be caused by free rad-
ical production during the metabolism of these com-
pounds, the present study was undertaken. We exam-
ined whether the modifiers of hepatocyte xenobiotic
metabolism, SKF-525A and diethyl maleate (DEM),
and the antioxidants, ot-tocopherol acetate (vitamin E),
N,N'-diphenyl-p-phenylenediamine (DPPD), and su-
peroxide dismutase (SOD), could alter the toxicity of
CHC13and CC14to isolated B6C3F1 mousehepatocytes.
SKF-525Ais aninhibitoroftheMFOS, DEM decreases
intracellular GSH levels, Vitamin E and DPPD arefree-
radical scavengers, and SOD dismutates superoxide
radicals to hydrogen peroxide.
Materials and Methods
Animals
Six-month-old male B6C3F1 mice were used in this
study. They were bred at the Medical College of Ohio
from C3H/He sires and C57BI/6 dams (Charles River
Laboratories, Inc., Wilmington, MA). Mice were kept
in plastic cages (five per cage) containing corncob bed-
ding and given water and certified Purina Lab Chow ad
libitum.
Chemicals
Leibovitz's L-15 medium and gentamicin were pur-
chased from Grand Island Biological Co. (Grand Island,
NY); fetal bovine serum, from Hyclone Laboratories
(Logan, UT); CHC13 and CC14, from Aldrich Chemical
Co. (Madison, WI); and DEM, a-tocopherol acetate,
DPPD, SOD, dimethyl sulfoxide (DMSO), dexametha-
sone and glucose, from Sigma Chemical Co. (St. Louis,
MO). SKF-525A was a gift from Smith, Kline and
French Laboratories (Philadelphia, PA). All other re-
agents were purchased from Sigma Chemical Co.
Hepatocyte Isolation and Culture
Mouse hepatocytes were isolated bytwo-stage in situ
perfusion (14). Cell viability of the isolated cells was
90%-95%, as determined by exclusion of trypan blue.
Hepatocytes were cultured in L-15 medium supple-
mentedwithglucose (1 mg/mL), dexamethasone (1 ,uM),
fetal bovine serum (10%), and gentamicin (50 ,ug/mL).
The hepatocytes were plated at a density of 0.5 x 106
cells per 60 mm dish and incubated in a humidified 100%
air incubator at 37°C.
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FIGURE 1. Toxicity ofchloroform (CHC13) to primary cultured male
B6C3F1 mouse hepatocytes after 2-, 4-, or 20-hr treatment. Each
point represents the mean (n=3) of the percent total LDH re-
leased.
Cytotoxicity Assay
Afterinitial platingand a4-hr attachment period, the
cultured cells were washed once and re-fed with 5 mL
of fresh medium. The cultures were then treated with
the test compounds. All compounds, except SOD, were
dissolved in DMSO. The final concentration of DMSO
in all cultures, except foruntreated cultures, was 0.4%.
After 2, 4, and 20 hr of treatment, aliquots of the me-
diumwereremoved, filteredthrough Nitrexnylonmesh
to remove cells, and analyzed forlactate dehydrogenase
activity (LDH) onaBeckmanMultistatAnalyzer(Beck-
man Instrument Corp., Palo Alto, CA). Total LDH per
culture was also determined from 0.01% Triton X-100
lysates of untreated cultures, mean of three dishes.
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FIGURE 2. Toxicity of carbon tetrachloride (CC14) to primary cul-
tured male B6C3F1 mouse hepatocytes after2-, 4-, or20-hr treat-
ment. Each point represents the mean (n=3) ofthe percent total
LDH released.
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Table 1. Effects of the metabolic inhibitors, SKF-525A and diethyl maleate, on chloroform toxicity in primary cultured B6C3F1
mouse hepatocytes.
Treatments Percent total LDH release at time
CHC13 mM Inhibitora 2 hr 4 hr 20 hr
0.0 None 5.6 ± 1.7b 5.7 ± 1.2 14.3 ± 2.3
0.0 SKF-525A 6.4 ± 0.9 6.8 ± 0.5 24.2 ± 1.0*
0.0 DEM 7.5 ± 1.4 7.8 ± 1.4 17.3 ± 1.3
1.0 None 16.8 ± 2.1 16.3 ± 1.9 27.0 ± 2.7
1.0 SKF-525A 12.6 ± 2.0 15.7 + 2.4 38.9 ± 1.9*
1.0 DEM 28.3 ± 0.7* 48.8 ± 2.9* 54.4 ± 2.7*
2.5 None 25.7 ± 2.4 26.9 ± 3.9 33.3 ± 3.3
2.5 SKF-525A 15.8 ± 5.2* 19.7 ± 3.0 52.2 ± 1.8*
2.5 DEM 47.0 ± 0.6* 58.7 ± 1.8* 65.1 ± 2.0*
5.0 None 42.7 ± 5.1 44.9 ± 4.7 58.3 ± 6.0
5.0 SKF-525A 25.0 ± 0.9* 33.3 ± 0.9* 67.5 ± 2.9
5.0 DEM 57.0 ± 1.3* 65.9 ± 2.8* 73.2 ± 2.4*
aInhibitor concentrations were 25 ,uM for SKF-525A and 0.25 ,uM for diethyl maleate (DEM).
bMean ± SD (n =3).
*Significant difference versus the corresponding CHCl3-only treatment.
Table 2. Effects of metabolic inhibitors, SKF-525A and diethyl maleate, on carbon tetrachloride toxicity in primary cultured B6C3F1
mouse hepatocytes.
Treatments Percent total LDH release at time
CC14 mM Inhibitora 2 hr 4 hr 20 hr
0.0 None 8.0± 1.Ob 8.9 ± 1.5 14.8 ± 1.0
0.0 SKF-525A 7.9 ± 0.6 8.6 ± 0.4 24.7 ± 0.6*
0.0 DEM 7.5 ± 0.4 12.8 ± 2.4 16.3 ± 1.3
1.0 None 53.0 ± 4.8 49.3 ± 3.5 73.6 ± 2.2
1.0 SKF-525A 36.1 ± 6.9* 40.8 ± 8.5 80.7 ± 5.2
1.0 DEM 72.8 ± 2.7* 73.9 ± 4.8* 86.6 ± 0.9*
2.5 None 65.5 ± 1.6 66.8 ± 2.8 76.4 ± 5.0
2.5 SKF-525A 52.7 ± 7.7* 55.9 ± 5.1* 85.4 ± 4.6
2.5 DEM 74.4 ± 3.2* 75.5 ± 4.2* 88.0 ± 2.3*
aInhibitor concentrations were 25 ,uM for SKF-525A and 0.25 puM for diethyl maleate (DEM).
bMean ± SD (n =3).
*Significant difference versus the corresponding CCl4-only treatment.
Table 3. Effects of the antioxidants DPPD, vitamin E, and superoxide dismutase on chloroform toxicity in primary cultured B6C3F1
mouse hepatocytes.
Treatments Percent total LDH release at time
CHC13, mM Antioxidanta 2 hr 4 hr 20 hr
0.0 None 5.6 ± 1.7b 5.7 ± 1.2 14.3 ± 2.3
0.0 DPPD 5.1 ± 0.6 5.6 ± 0.4 11.8 ± 0.3
0.0 Vitamin E 7.3 ± 1.3 7.9 ± 0.9 16.0 ± 0.7
0.0 SOD 4.4 ± 0.3 4.7 ± 0.5 12.3 ± 1.1
1.0 None 16.8 ± 2.1 16.3 ± 1.9 27.0 ± 2.7
1.0 DPPD 9.0 ± 0.4* 5.7 ± 1.6* 14.3 + 0.5*
1.0 Vitamin E 14.4 ± 3.5 14.8 ± 2.6 25.9 ± 3.2
1.0 SOD 9.0 ± 2.3* 13.4 ± 2.4 19.3 ± 2.6*
2.5 None 25.7 ± 2.4 26.0 ± 3.9 33.3 ± 3.3
2.5 DPPD 14.5 ± 0.9* 10.4 ± 0.2* 24.3 ± 1.9*
2.5 Vitamin E 14.0 ± 0.6* 12.5 ± 0.9* 18.6 ± 0.7*
2.5 SOD 12.1 ± 1.4* 14.3 ± 1.1* 19.7 ± 1.5*
5.0 None 42.7 ± 5.1 44.9 ± 4.7 58.3 ± 6.0
5.0 DPPD 30.3 ± 1.7* 33.2 ± 0.6* 47.5 ± 0.8*
5.0 Vitamin E 19.7 ± 2.3* 20.0 ± 2.4* 27.7 ± 2.8*
5.0 SOD 30.0 ± 4.9* 33.6 ± 2.8* 41.0 ± 2.7*
aAntioxidant concentrations were 25 p.M for DPPD, 0.1 mM for vitamin E, and 100 U/mL for SOD.
bMean ± SD (n =3).
*Significant difference versus the corresponding CHCl3-only treatment.
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Table 4. Effects of the antioxidants DPPD, vitamin E, and superoxide dismutase on carbon tetrachloride toxicity in primary cultured
B6C3F1 mouse hepatocytes.
Treatments Percent total LDH release at time
CCl4, mM Antioxidanta 2 hr 4 hr 20 hr
0.0 None 8.0 ± 1.0b 8.9 ± 1.5 14.8 ± 1.0
0.0 DPPD 5.7 ± 1.5 6.2 ± 1.4 12.3 ± 1.3
0.0 Vitamin E 7.7 ± 0.6 6.9 ± 0.2 13.8 ± 0.8
0.0 SOD 7.5 ± 0.6 9.9 ± 0.8 14.8 ± 1.1
1.0 None 53.0 ± 4.8 49.3 ± 3.5 73.6 ± 2.2
1.0 DPPD 28.5 ± 3.6* 30.9 ± 5.7* 47.6 + 4.4*
1.0 Vitamin E 40.4 ± 3.6* 34.8 ± 3.9* 60.1 ± 2.3*
1.0 SOD 36.9 ± 2.2* 37.7 ± 2.5* 58.3 ± 4.6*
2.5 None 65.5 ± 1.6 66.8 ± 2.8 76.4 ± 5.0
2.5 DPPD 44.2 ± 4.6* 50.0 ± 7.0* 61.0 5.9*
2.5 Vitamin E 45.2 ± 5.2* 40.6 ± 5.7* 62.7 3.9*
2.5 SOD 42.9 ± 3.0* 41.9 ± 2.1* 60.0 ± 1.4*
aAntioxidant concentrations were 25 ,uM for DPPD, 0.1 mM for vitamin E, and 100 U/mL for SOD.
bMean ± SD (n=3).
*Significant difference versus the corresponding CCl4-only treatment.
LDH in unused, fresh culture medium was also deter-
mined to indicate initial LDG levels in the cultures.
Cytotoxicity in a culture was expressed as the "percent
total LDH released" by using the formula (15-17):
%LDH
LDH in medium oftreated culture - LDH in unused medium
mean total LDH - LDH in untreated medium
x 100%
Values for the percent total LDH released were deter-
mined in threereplicate cultures foreachtreatment and
samplingtime, and the means ±S.D. were determined.
Different treatments were compared statistically using
Student's t-test.
Results
The toxicity ofCHC13 to isolated B6C3F1 mouse he-
patocytes was dependent on dose and treatment dura-
tion (Fig. 1). Little increase in LDH leakage was evi-
dent in cultures treated with less than 1.0 mM CHC13.
CC14toxicity was alsodependent ondose and treatment
duration (Fig. 2). As with CHC13, little difference in
LDH release was evident between the 2-hr and 4-hr
samplingtimes, and LDH release was greatest after 20
hroftreatment. CC14 was approximately 16times more
toxicthanCHC13tothehepatocytes. Percenttotal LDH
activities of50% occurred with approximately 0.25 mM
CC14 and 4.0 mM CHC13 at the 20-hr sampling time
(Figs. 1 and 2).
TheadditionofSKF-525A(25 ,uM) to CHC13- orCC14-
treated cultures could be shown to significantly reduce
LDH release below that of cultures treated only with
CHC13 or CC14 (Tables 1 and 2). This effect was evident
onlyatthe2-hrand4-hrsamplingtimes. At20hr, SKF-
525A was cytotoxic byitselfand eitherincreased orhad
no effect on LDH release in CHC13- and CC14-treated
cultures. Adding DEM (0.25 mM) to CHC13- or CC14-
treated cultures significantly increased LDH release
above CHC13- or CCl4-only treated cultures (Tables 1
and 2). This effect was evident at 2, 4, and 20 hr. DEM
was not toxic by itself.
The antioxidants, DPPD (25 ,uM), vitamin E (0.1
mM), and SOD (100 U/mL), when added to CHC13- and
CC14-treated cultures, significantly reduced hepatocyte
toxicity below that of cultures treated with CHC13 or
CC14alone (Tables3 and4). Withthe highdose ofCHC13
(5 mM), vitamin E best prevented cytotoxicity com-
pared to SOD and DPPD (Table 3). No differences in
antioxidant protection were evident with 2.5 mM
CHC13. DPPD provided the greatest protection against
low-dose CHC13 (1 mM)toxicity. Cytotoxicity ofthe low
CC14 dose (1.0 mM) was best prevented by DPPD,
whereas no differences between the antioxidants were
apparent with the high CC14 dose (2.5 mM) (Table 4).
Discussion
Theresults ofthisstudyindicatethatCHC13and CC14
are cytotoxic to primary cultured B6C3F1 mouse he-
patocytes. Both compounds exhibited dose- and time-
dependent effects. CC14 was approximately 16 times
more toxic than CHC13. Previous studies have also in-
dicated that CC14, is more hepatotoxic than CHC13 (2,
3).
CHC13- and CCl4-induced cytotoxicity was decreased
by the simultaneous treatment of SKF-525A, an inhib-
itor of mammalian MFOS. These results substantiate
previous studies that indicated both CHC13 and CC14
are metabolized in hepatocytes by the MFOS to hepa-
totoxicmetabolites (9, 11). InthecaseofCC14, theinitial
reaction is a reduction and homolytic cleavage of CC14
to the trichloromethyl radical (KCC13). This radical may
reactdirectlywithcellularmacromolecules ormayreact
with oxygen to form the trichloromethylperoxyl radical
( OOCC13), which may then attack lipids more readily
than 'CC13 (10). In any event, the initiation offree rad-
icals and attack on membrane lipids ultimately can lead
to lipid peroxidation chain reactions and cell death (10).
CHC13 is thought to be first hydroxylated by a P-450
reaction to trichloromethanol (CC130H), which dehy-
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drochlorinates spontaneously to phosgene (COC12) (11).
Phosgene isthought tocovalently bind cellularmacrom-
oleculesandtobetheultimatecytotoxic component (11).
However, two reports (12, 13) have suggested that
CHC13 is metabolized tofree radicals and thatit induces
lipid peroxidation.
The results of the present study suggest that free
radical production is an important mechanism of both
CC14 and CHC13 toxicityin B6C3F1 mousehepatocytes.
The antioxidants SOD, DPPD, and vitamin E all sig-
nificantly reduced the toxicity of CC14 and CHC13 to
these cells. Similarly, depletion of cellular glutathione
(GSH) (with DEM), increased CC14 and CHC13 toxicity
to the hepatocytes. GSH functions both as an antioxi-
dant and in the conjugation of xenobiotic metabolites
(18).
Thus, the results of this initial study indicate that
both CC14 and CHC13 are metabolized in B6C3F1 mouse
hepatocytes by the MFOS, that cellular GSH is impor-
tantinthe detoxification ofCC14 and CHC13metabolites
and/or induced free radicals, and that the cytotoxicity
of both compounds might be partly mediated by free
radicalproduction. Previous studies have demonstrated
the role of free radicals and lipid peroxidation in CC14-
mediated hepatotoxicity. However, evidence that
CHC13-induced hepatotoxicity is mediated by free rad-
icals has been less substantiated. The results of the
present study provide additional evidence that, in
mouse hepatocytes, free radical production may be an
important mechanism of CHC13-induced toxicity.
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